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Summary.-Selected monoclonal antibodies (McAbs) isolated after immunization of
rats with a human colonic carcinoma membrane preparation, have been screened on
frozen and paraffin sections ofcolonic tissue, using immunohistochemical techniques,
in order to provide additional information with regard to specificity and cross-
reactivity with normal tissues.
Of 10 McAbs previously shown to bind to a colonic carcinoma membrane prepara-
tioninaradioimmunoassay,7showspecificstainingwhentested by indirect immuno-
fluorescence on crysotat sections of colonic tissue. Three of these 7 show activity on
both normal and malignant colonic epithelium, and the remaining 4 stain normal
epithelium, with little or no activity on malignant tissue. In the indirect immuno-
fluorescent and immunoperoxidase techniques on paraffin sections of the same mat-
erial, only 2 McAbs retain activity; one detects an antigen in colonic mucus, and the
other recognises an antigen which is sparse on normal colonic epithelium and
abundant on colonic tumours.
We conclude that screening of McAbs on frozen tissue sections, using indirect
immunofluorescence, is a useful adjunct to conventional screening methods, e.g.
binding to membrane preparations and/or cell lines in a radioimmunoassay. These
techniques distinguish McAbs with similar binding values in conventional assays,
identify their activity on a wide range of normal and malignant tissues, demonstrate
antigens that are lost or gained in malignant transformation and finally assist in the
selection of McAbs for further extensive study before possible clinical use.
MONOCLONAL ANTIBODIES (McAbs) pro-
duced by the cell-fusion technique (Kohler
& Milstein, 1975) are replacing conven-
tional antisera in many areas of basic and
applied research, and have provided new
tools for serological comparison of normal
and malignant tissues. Several strategies
are used to make McAbs for this com-
parison, and, although the fusion proto-
cols are now fairly well established
(Galfre & Milstein, 1981) there is much
variety both in immunization and in the
screening of fusion products for antibody
activity.
One approach, used by several workers,
has been to use established tumour cell
lines both for the initial immunization
and as a target to screen for antibody
activity. Specificity for individual McAbs
is then defined by comparison on other
cell lines. In this way McAbs to melanoma
cell lines (e.g. Koprowski et al., 1978) and
colorectal carcinoma cell lines (e.g. Herlyn
et al., 1979) have been produced.
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An alternative approach, which avoids
the possible bias which may be introduced
by using cells in permanent culture, is to
use fresh tumour material. A tumour-
membrane preparation is used as the
immunogen and the screening uses the
same preparation, bound to plastic wells,
in a solid-phase radioimmunoassay. Whilst
this screening method is rapid and capable
of dealing with many samples, it gives
little information about the specificity of
the antibody or the tissue distribution of
the antigenic determinant recognized. To
gain this information, we have investiga-
ted the utility of screening on sections of
normal and malignant tissue as an adjunct
to screening on membrane preparations.
Using McAbs raised against a human
colonic-carcinoma membrane preparation
(Takei & Lennox, unpublished) and selec-
ted for binding to the same membranes,
we examined activity on both frozen and
paraffin-embedded sections of normal and
malignant colonic tissue, using standard
immunohistochemical techniques. In this
way we were able to discriminate between
McAbs giving similar total binding values
in the radioimmunoassay and to identify
those that detected loss or gain ofantigens
on malignant tissue. It was also possible to
extend these studies to include a variety
of normal and malignant tissues, and so
learn more of the specificity and cross-
reactivity of individual McAbs.
MATERIALS AND) METHODS
Clone:d cell lines producing rat McAbs were
isolated by two fusion experiments in which
rats were immunized with a human colonic-
carcinoma membrane preparation (Takei &
Lennox, unpublished). Screening for antibody
in the fusion wells and from the cloned
hybrid lines wNas performed on the same mem-
brane preparations bound to plastic wells in a
-solid-phase radioimmunoassay. Undiluted
active supernatants wrere stored at - 20°C.
Aliquots for use in the immunohistochemical
techniques were kept at 40C.
Specimens ofnormal and malignaint colonic
tissue were obtained fresh from the operating
heatre. For immunohistology, samples of
TABLE I. Technique for staining sections
by indirect imrnmunofuorescence
1. Air-dry frozeni sections 3-5 min.
'. Fix sections in 5% formol saline 5 mm.
3. Waslh in phosplhate-buffered saline (PBS)----1
min.
4. (Optional) Incubate with normal serum corres-
ponding to second antibody layer. 1 in 10
dilution in PBS-10 min.
5. Washl in PBS 10 min.
6. Incubate with 100 ,ul of monoclonal supernatant
in moist chamber 30 min.
7. Wash in PBS 2 x 15 min.
S. Incubate with (FITC) conjugated secoindl ainti-
body (100 tl of 1-in-20-1-in-100 (lilution 30
min. (Miles Yeda Ltd).
9. Wash in PBS 2 x 15 min.
10. Stain with 0-1% Evans blue solutioin ((loss &
Aarli, 1973).
11. Wash in PBS-2 x 10 min.
12. Mount in glycerol-buffer Inixture (Nail-I,
1976) pH 8-6.
13. Seal with paraffin wax.
normal and malignant tissue were taken
quickly from the unfixed specimen, placed
together in embedding capsules (E.M. Scope
Labs. Ltd.) in a gelatin solution (700 gelatin
in 0-900 NaCl+0 0500 sodium azide) and
snap-frozen in liquid N2. Frozen capsules
were stored at -70Cc until required. The
remaining portions ofcolon were fixed in 10%
buffered formol saline, and embedded in
paraffin wax in the routine manner.
Indirect immunofluorescent assays were
performed on frozen sections of normal and
malignant colonic epithelium. The essential
steps of the present method are shown in
Table 1. Five-micron sections were cut at
-20°C in a cryostat (Brights), placed on
multiwell slides (Hendley-Essex) and air-
dried. Additional sections were cut and
stored unfixed at -20°C, either in or out of a
dessicator, for up to one month. Comparative
studies using unfixed material, fixation with
950o ethanol at 4°C for 10 min, acetone at
4°C for 10 min and 50 formol saline for 5 or
10 min, were performed. Antibody-free
medium (Dulbecco's Modified Eagle's medium
+10% foetal calf serum) and phosphate-
buffered saline (Dulbecco "A" tabs-Oxoid)
were used as negative controls. Slides were
examined with a Zeiss fluorescent microscope
and activity recorded on Kodak Tri X Pan
Film (ASA 400) using an M35 Zeiss camera.
The method for indirect immunofluores-
cence on paraffin sections was as in Table I
(Step 3 onwards). Sections were previously
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TABLE II.-Techniquefor staining sections
by indirect immunoperoxidase
1. Dewax sections in xylene and rehydrate
through alcohols-10 min.
2. Inhibit endogenous peroxidase with 5% aqueous
H202-10 min.
3. Wash in tap water-20 min.
4. Rinse in distilled water-10 min.
5. Incubate with normal serum corresponding to
second antibody layer, 1 in 10 dilution in PBS-
10 min.
6. Rinse with PBS.
7. Incubate with 100 ,ul ofmonoclonal supernatant
in moist chamber-30 min.
8. Wash in PBS-2 x 10 min.
9. Incubate with peroxidase conjugated second
antibody layer (100 ul of 1-in-50-1-in-100 dilu-
tion)-30 min. (Miles Yeda Ltd).
10. Wash in PBS-2 x 10 min.
11. Cover with freshly prepared diaminobenzidine
(DAB) solution (DAB 10 mg, 40 ,ul H202 and 20
ml PBS)-5 min.
12. Rinse in PBS
13. Counterstain with Mayer's haemalum, blue in
tap water.
14. Dehydrate through alcohols, clear in xylene and
mount in DPX.
deparaffinized in xylene and rehydrated
through alcohols.
Indirect immunoperoxidase staining of
paraffin sections of formalin-fixed tissue was
as described by Heyderman (1979) with
minor modifications. The technique is shown
in Table II. Seven-micron sections were cut
from paraffin blocks and placed on standard
microscope slides, previously immersed in a
0.5% gelatin solution (containing 250 mg of
chrome alum and 30 mg of sodium azide/100
ml) and dried overnight (Heyderman,
personal communication). Sections were
photographed with a Zeiss M35 camera
on to KB14 film (ASA 20).
RESULTS
Ten McAbs from 2 fusion experiments
were screened on specimens ofnormal and
malignant colonic tissue from 4 patients
(Table III).
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FiG. 1. Indirect immunofluorescence (IF) of McAbs on normal and malignant colonic epithelium.
(a) YPC 2/13.14 on frozen section ofnormal colonic epithelium (right) adjacent to malignant epithel-
ium (left), showing reduced activity in tumour. (b) YPC 1/3.12 on frozen section ofnormal colonic
epithelium, showing activity in smooth muscle of muscularis mucosae. (c) YPC 2/38.9 on similar
field to a, showing staining of cell membrane of normal and malignant cells. (d) YPC 2/44.3 on
frozen section of normal colonic epithelium, staining goblet cells and colonic mucus.
Indirect iminunofluorescence
Indirect immunofluorescence on cryo-
stat sections showed specific activity of 7
McAbs on sections whether unfixed or
fixed with 5% formol saline for 5 or 10
min. Although morphology was preserved
in sections fixed with either ethanol or
acetone, one ofthe 7, YPC 1/3.12, was not
active on sections thusfixed. On no section
from any ofthe 4 specimens, whetherfixed
or unfixed, did the 3 McAbs YPC 2/29.4,
YPC 2/45.3 or YPC 2/47.3 show any
activity.
Three McAbs (YPC 1/1.1, YPC 2/9.12
and YPC 2/13.14) stained normal colonic
epithelium in all samples but had little or
no activity on colonic tumours; e.g.
YPC 2/13.14 in Fig. la. Although the 3
yielded a similar amount ofbinding in the
membrane assay (Table III), on the tissue
sections there were distinct and recogniz-
able differences amongst them either in
the distribution of staining on the indi-
vidual cells or in the pattern of activity
over the whole epithelial surface. In
general the pattern of activity for each
McAb was consistent on the 4 specimens
examined; however, one McAb (YPC
2/9.12) showed little activity on one ofthe
specimens of normal colon.
One antibody (YPC 1/3.12) was local-
ized to the smooth-muscle layers of the
bowel wall-both the muscularis mucosae
(Fig. lb) and the outer muscular coats of
colon. It was also present in the walls of
blood vessels. This activity was neither
species-specific (being present in the gut
and blood vessels of the mouse, chicken
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FIG. 2- As in Fig. 1 usiIng single McAb-YPC 2/12.1. (a) Frozen section ofmalignant colonic epithel-
ium. Staining of luminal border of cells and debris within tumour. (b) Frozen section of normal col-
onic epithelium. Staining along epithelial surface only. (c) Similar field to Fig. la & c, showing
staining of tumour and fine line of activity on normal epithelium.
and frog) nor organ-specific (being present
in chicken gizzard) (de Mattos, unpub-
lished).
The 3 McAbs YPC 2/12.1, YPC 2/38.9
and YPC 2/44.3 stained both normal and
malignant tissue, but again each had its
individual and recognizable pattern of
activity. YPC 2/38.9 (Fig. 1c) stained the
cell membrane of both normal and malig-
nant cells. There appeared to be little
staining of either intracellular or extra-
cellular contents. Fig. Id demonstrates the
activity of McAb YPC 2/44.3, which
recognized an antigen in colonic mucus.
The maximal staining was of the goblet
cells and the mucus coating the surface of
the colon. This McAb stained 3 of the 4
tumours examined. The McAb YPC 2/12.1
stained all 4 colonic tumours, the maximal
staining being in the debris within the
tumour (Fig. 2a). However, as is shown in
Fig. 2b & c there was staining also of the
normal colonic epithelium, where the
antigen was restricted to a thin line on the
surface of the colon. All 10 McAbs were
also tested on 2 specimens of normal
colonic tissue removed for diverticular
disease rather than malignant disease. The
same staining patterns of the 7 positive
McAbs, previously noted on normal por-
tions of colon removed with tumours,
were demonstrated on both these speci-
ment by indirect immunofluorescence.
Storage
Frozen sections ofnormaland malignant
colonic epithelium were stored, after air-
drying, at - 200C, either in or out of a
dessicator, for up to one month. When
these sections were used in indirect
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FiG. 3.-Comparison of staining reactions in similar fields from paraffin sections containing normal
(right) and malignant tissue (left). (a) and (b) indirect immunofluorescence, (c) and (d) indirect
immunoperoxidase, using McAbs YPC 2/12-1 (a,c) andYPC 2/44-3(b, d). (a) Staining within tumour,
faint activity on surface ofnormal colon. (b) Staining ofnormal epithelium only. (c) Staining ofthe
malignant epithelium. (d) Extranuclear granular staining on normal epithelium.
immunofluorescence with the same McAbs,
there was no apparent loss ofantigens.
Paraffin-embedded material
When the same 10 McAbs were used in
the indirect immunofluorescence tech-
nique (using the same FITC-RARIG as
for frozen sections) on formalin-fixed,
paraffin-embedded sections of the same
material, only 2 retained their activity:
YPC 2/12.1 and YPC 2/44.3.
McAb YPC 2/44.3 stained all normal
colonic epithelium, either as an intra-
cellular granular stain or as a diffuse stain
ofthe goblet cells and extracellular colonic
mucus. It stained the same 3 colonic
tumours that were positive on frozen
sections, and these tumours were shown to
be mucus-secreting adenocarcinomas on
using a conventional alcian blue stain.
The other McAb to retain activity on
paraffin sections was YPC 2/12.1. This
stained all 4 tumours examined; both as
an apical intracellular stain and as a dense
stain of the extracellular debris within the
tumour bulk. There were traces ofactivity
with YPC 2/12.1, on the normal epithelial
surface but not as definite as on frozen
sections. Fig. 3a & b show the respective
patterns of fluorescence obtained with
YPC 2/12.1 and YPC 2/44.3 on paraffin
sections containing normal and malignant
colonic tissue.
Indirect immunoperoxidase
When all 10 McAbs were used in an
indirect immunoperoxidase technique on
paraffin-embedded sections, similar re-
sults to indirect immunofluorescence were
obtained. Only YPC 2/12.1 and YPC
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2/44.3 retained activity. This is demon-
strated in Fig. 3c & d, the same fields as
Fig. 3a & b. Although the patterns of
activity with YPC 2/12.1 and YPC 2/44.3
were similar on both frozen and paraffin
sections, the morphological detail was
better on the latter, particularly using the
indirect immunoperoxidase technique.
An extension of these studies using
indirect immunoperoxidase staining has
shown activity with McAb YPC 2/12.1 on
all of 30 colonic tumours of varying
degrees of differentiation and from all
parts of the large bowel. Metastatic
deposits in regional lymph nodes were also
detected. McAb YPC 2/44.3 shows activity
on normal bronchial epithelium but not
normal gastric epithelium, except in areas
showing intestinal metaplasia (unpub-
lished).
DISCUSSION
Many attempts are being made to
produce McAbs that recognize antigens
present on the surface of malignant cells,
but not their normal counterparts. In
general, cultured malignant cell lines are
being used to elicit and detect these anti-
bodies. Although some of them appear to
be tumour-specific at present (Colcher et
al., 1981) many others have been found,
on further study, to react with cells other
than the tumour cell (Koprowski et al.,
1978; Dippold et al., 1980; Brown et al.,
1981). Clearly, testing the specificity of
individual McAbs, particularly for cross-
reactions with normal tissue, is of the
utmost importance prior to their use in
clinical situations: e.g. targeting of radio-
isotopes, chemotherapeutic agents or tox-
ins (Lennox, 1982; Lennox & Sikora,
1982). This screening is difficult to do with
established cell lines which may poorly
represent normal resting tissues, for
whilst tumour-cell lines provide a constant
and renewable source of material, and
extensive screening can be performed on
many lines, they may not be representa-
tive ofthe many cell types or physiological
states of the tumour as a whole.
An alternative method for selecting
2
McAbs is to screen for activity on tumour-
membrane preparations, bound to plastic
wells, in a solid-phase radioimmunoassay.
Although this method is satisfactory for
selecting positive McAbs, it provides little
information about the comparative activ-
ity on normal and malignant tissue or on a
particular cell type. It was for this reason
that we compared the McAbs by histo-
logical screening on frozen tissue sections
using indirect immunofluorescence, in
addition to screening on many cell lines
and membrane preparations from several
colonic tumours. We also compared, using
indirect immunofluorescence, frozen sec-
tions with sections of routine formalin-
fixed paraffin-embedded material, avail-
able in any pathology laboratory.
Screening on frozen sections appears to
have several advantages. Using the in-
direct immunofluorescence technique, sev-
eral McAbs, with similar binding values in
the radioimmunoassay, show very differ-
ent patterns of activity on tissue sections,
and hence are likely to be detecting
different antigens, e.g. YPC 2/12.1, YPC
2/44.3 and YPC 2/38.9, all of which show
strong binding to membranes. Further-
more, the histological distribution of
activity can give clues for the e-xtension of
studies on different tissues, e.g. YPC
1/3.12, which is active on smooth muscle
and myoepithelial cells of mammary
tissue (de Mattos, unpublished8
Screening on frozen sections has also
allowed us to identify McAbs wit.h strong
activity on malignant epithelium (e.g.
YPC 2/12.1) and, just as important,
McAbs that recognize antigens on normal
tissue which appear to be partially or
completely lost by malignant tissue (e.g.
YPC 1/1.1 and YPC 2/13.14). There was a
good correlation between binding to
membranes in a radioimmunoassay and
presence of activity on frozen tissue
sections. However, there remain 3 weak-
binding McAbs, which were negative in all
sections: YPC 2/29.4, YPC 2/45.3 and
YPC 2/47.3. Although none ofthe 3 bound
strongly to the membranes (Table III)
they were apparently positive in binding
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with various tumour-cell lines, including
the colon-carcinoma lines HT29 (Fogh &
Trempe, 1975) and LS174T (Tom et al.,
1976) and so had been retained. It is
likely, since their binding to these cell
lines is also weak, that these 3 McAbs
were incorredtly selected. It is also
possible that their antigens did not survive
formol-saline fixation, though none of
them was active on unfixed tissue or
tissue fixed with ethanol or acetone. The
activity of one McAb (YPC 1/3.12) was
lost after fixation with ethanol or acetone
but survived formol saline.
Storage of frozen sections after air-
drying, either in or out of a dessicator at
- 20°C, for up to one month, did not
result in antigenic loss. Indeed, further
studies in progress suggest that many of
the antigens recognized are still present on
sections after 6 months' storage.
Our experience with a parallel study of
frozen and paraffin-embedded material
using indirect immunofluorescence con-
firms that many antigens are lost during
paraffin embedding. Of the 7 McAbs
positive on cryostat sections, 5 were
negative on paraffin sections. We com-
pared frozen sections ofcolonic tissue with
routinely fixed paraffin-embedded speci-
mens of the same tissue, processed by the
hospital pathology department, to deter-
mine how useful these standard blocks
would be for histological screening. It is
apparent that many potentially useful
McAbs, directed to antigenic determinants
present on normal and malignant tissues
and also to antigens lost by malignant
tissue (e.g. YPC 2/13.14) would have been
discarded if screening had been limited to
paraffin blocks. We conclude that histo-
logical screening on frozen sections yields
maximum information at the outset. If
McAbs are being produced in order to
conduct retrospective studies on routinely
fixed paraffin-embedded material, they
should be screened at an early stage for
activity on such tissue.
The screening of fusion products for
some desired activity is a time-consuming
step in McAb production. Techniques have
to be quick, simple and reliable. We feel
that there is a place for the introduction of
histological screening at an early stage in
the production of McAbs. These methods
can demonstrate the distribution of anti-
gens on normal and malignant tissues,
and, by screening on a wide variety of
tissues, reveal possible cross-reactivity.
The techniques also serve to distinguish
between antibodies which have similar
binding values in the conventional screen-
ing systems using cell lines and membrane
preparations. Moreover, they are es-
pecially good for revealing antigenic loss
in malignant transformation. Detection of
such losses might be turned to good
advantage in the early diagnosis of
malignant disease. Finally, the possible
clinical use of McAbs as carriers of toxic
agents (Olsnes, 1981) demands that more
be learnt of the specificity of individual
McAbs, particularly their cross-reactivity
with a wide variety ofnormal tissues, and
for this purpose there is at present no
generally available substitute for histo-
logical screening.
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